These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1081 related articles for article (PubMed ID: 29556336)

  • 1. Current Strategies for Brain Drug Delivery.
    Dong X
    Theranostics; 2018; 8(6):1481-1493. PubMed ID: 29556336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
    Pinheiro RGR; Coutinho AJ; Pinheiro M; Neves AR
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle transport across the blood brain barrier.
    Grabrucker AM; Ruozi B; Belletti D; Pederzoli F; Forni F; Vandelli MA; Tosi G
    Tissue Barriers; 2016; 4(1):e1153568. PubMed ID: 27141426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics.
    Tang W; Fan W; Lau J; Deng L; Shen Z; Chen X
    Chem Soc Rev; 2019 Jun; 48(11):2967-3014. PubMed ID: 31089607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Strategies to Enhance Delivery of Drugs across the Blood-Brain Barrier.
    Teleanu RI; Preda MD; Niculescu AG; Vladâcenco O; Radu CI; Grumezescu AM; Teleanu DM
    Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoneurotherapeutics approach intended for direct nose to brain delivery.
    Md S; Mustafa G; Baboota S; Ali J
    Drug Dev Ind Pharm; 2015; 41(12):1922-34. PubMed ID: 26057769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable Nanoparticles for Delivery of Therapeutics in CNS Infection.
    DeMarino C; Schwab A; Pleet M; Mathiesen A; Friedman J; El-Hage N; Kashanchi F
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):31-50. PubMed ID: 27372507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive nanoparticle strategies for brain tumor targeting.
    Sun C; Ding Y; Zhou L; Shi D; Sun L; Webster TJ; Shen Y
    Nanomedicine; 2017 Nov; 13(8):2605-2621. PubMed ID: 28756093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nano carriers for drug transport across the blood-brain barrier.
    Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
    J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theranostic applications of nanoparticles in neurodegenerative disorders.
    Ramanathan S; Archunan G; Sivakumar M; Tamil Selvan S; Fred AL; Kumar S; Gulyás B; Padmanabhan P
    Int J Nanomedicine; 2018; 13():5561-5576. PubMed ID: 30271147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases.
    Saraiva C; Praça C; Ferreira R; Santos T; Ferreira L; Bernardino L
    J Control Release; 2016 Aug; 235():34-47. PubMed ID: 27208862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport of drugs across the blood-brain barrier by nanoparticles.
    Wohlfart S; Gelperina S; Kreuter J
    J Control Release; 2012 Jul; 161(2):264-73. PubMed ID: 21872624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactants, not size or zeta-potential influence blood-brain barrier passage of polymeric nanoparticles.
    Voigt N; Henrich-Noack P; Kockentiedt S; Hintz W; Tomas J; Sabel BA
    Eur J Pharm Biopharm; 2014 May; 87(1):19-29. PubMed ID: 24607790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transportation of Single-Domain Antibodies through the Blood-Brain Barrier.
    Ruiz-López E; Schuhmacher AJ
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-brain barrier P-glycoprotein function in neurodegenerative disease.
    Bartels AL
    Curr Pharm Des; 2011; 17(26):2771-7. PubMed ID: 21831040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent progress of drug nanoformulations targeting to brain.
    Khan AR; Yang X; Fu M; Zhai G
    J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the ATP-binding cassette transporter P-glycoprotein in the transport of β-amyloid across the blood-brain barrier.
    Vogelgesang S; Jedlitschky G; Brenn A; Walker LC
    Curr Pharm Des; 2011; 17(26):2778-86. PubMed ID: 21827406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for transporting nanoparticles across the blood-brain barrier.
    Zhang TT; Li W; Meng G; Wang P; Liao W
    Biomater Sci; 2016 Feb; 4(2):219-29. PubMed ID: 26646694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upconversion Nanoparticle-Based Strategy for Crossing the Blood-Brain Barrier to Treat the Central Nervous System Disease.
    Fu L; Chung R; Shi B
    Methods Mol Biol; 2019; 2054():263-282. PubMed ID: 31482461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-disciplinary Approach for Drug and Gene Delivery Systems to the Brain.
    Ndemazie NB; Inkoom A; Morfaw EF; Smith T; Aghimien M; Ebesoh D; Agyare E
    AAPS PharmSciTech; 2021 Dec; 23(1):11. PubMed ID: 34862567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.